Retrospective Analysis of Diagnostic and Prognostic Value of Serum Glypican-3 in Patients With HCV-Related Cirrhosis With Or Without HCC After Achieving SVR With DAA Treatment
While GPC-3 may be of limited utility for predicting HCC occurrence in patients cured of HCV, it could represent a valuable prognostic factor able to predict survival of patients with established HCC.
Authors
- Patrizia CARUCCI
- Yulia Troshina
- Eleonora Dileo (ORCID: https://orcid.org/0009-0006-4970-7762)
- S. Gaia
- Emanuela Rolle
- Marta Guariglia (ORCID: https://orcid.org/0000-0003-1389-7278)
- Francesca Saba (ORCID: https://orcid.org/0000-0001-5133-2994)
- Alessia Ciancio
- Gian Paolo Caviglia
Institutions
- Fondazione Ricerca Molinette (IT)
- Department of Medical Sciences (BY)
- University of Turin (IT)
Publication Details
- Journal
- Journal of Gastrointestinal Cancer
- Published
- 2026-01-09
- DOI
- https://doi.org/10.1007/s12029-025-01371-0
- Primary Topic
- Hepatitis C virus research
- Type
- article
- Field-Weighted Citation Impact
- 0.00